Funds and ETFs Gulf Pharmaceutical Industries

Equities

JULPHAR

AEG000201018

Pharmaceuticals

Market Closed - Abu Dhabi Securities Exchange 05:58:02 2024-04-29 am EDT 5-day change 1st Jan Change
0.941 AED -0.11% Intraday chart for Gulf Pharmaceutical Industries -1.98% +22.37%

ETFs positioned on Gulf Pharmaceutical Industries

Name Weight AuM 1st Jan change Investor Rating
0.00% 117 M€ +1.54% -
Gulf Pharmaceutical Industries PSC (Julphar) is a United Arab Emirates-based public shareholding company engaged in manufacturing and selling of medicines, drugs and other types of pharmaceutical and medical compounds, in addition to cosmetic compounds. The Company maintains a range of product portfolio, which target major therapeutic segments, including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management. The Company operates through a network of more than 10 manufacturing plants, and a logistics network. The Company has approximately 800 products in various dosage forms, and more in the pipeline. The Company’s subsidiaries include Mena Cool FZE, which is engaged in the transportation, and Julphar Pharmaceuticals PLC, which is engaged in Manufacturing of medicines, wrapping and packing materials.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.941 AED
Average target price
0.72 AED
Spread / Average Target
-23.49%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. JULPHAR Stock
  4. Funds and ETFs Gulf Pharmaceutical Industries